PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Open Medicine10.1515/med-2016-00032016111Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case reportTao Wang, Ruimin Wang, Zhouhuan Dong, Naichao Liang, Ping Changhttp://www.degruyter.com/view/j/med.2016.11.issue-1/med-2016-0003/med-2016-0003.xml, http://www.degruyter.com/view/j/med.2016.11.issue-1/med-2016-0003/med-2016-0003.pdf
Chest10.1378/chest.199456720141464591ANon-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation: Response to ChemotherapyUthara Vijai Kumarhttp://api.elsevier.com/content/article/PII:S0012369216498491?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0012369216498491?httpAccept=text/plain
Brain Metastases from Primary Tumors10.1016/b978-0-12-801419-6.00005-7201569-75Brain Metastasis from Non-Small Cell Lung Cancer: Use of Epidermal Growth Factor Receptor and HER2 Status for Targeted TherapyHyo Sup Shim, Ja Seung Koo, Se Hoon Kimhttp://api.elsevier.com/content/article/PII:B9780128014196000057?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:B9780128014196000057?httpAccept=text/plain
Cancer Treatment Reviews10.1016/j.ctrv.2013.05.0012013398839-850Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patientsMonic Roengvoraphoj, Gregory J. Tsongalis, Konstantin H. Dragnev, James R. Rigashttp://api.elsevier.com/content/article/PII:S0305737213000935?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0305737213000935?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(95)90545-61995132193Immunohistochemical evaluatin of E-cadherin and epidermal growth factor receptor in non-small cell lung cancerhttp://api.elsevier.com/content/article/PII:0169500295905456?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:0169500295905456?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(89)90104-9198952-3108Characterization of epidermal growth factor receptor in primary human non-small cell lung cancerhttp://api.elsevier.com/content/article/PII:0169500289901049?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:0169500289901049?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)93777-x1994112Epidermal growth factor receptor (EGFR) in non small cell lung cancer (NSCLC)http://api.elsevier.com/content/article/PII:016950029493777X?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:016950029493777X?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(13)70022-9201379S822 Epidermal growth factor receptor (EGFR) mutation testing in non small cell lung cancer – the New Cross Hospital experienceL. Dunphy, N. Murukesh, D.R. Ferryhttp://api.elsevier.com/content/article/PII:S0169500213700229?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0169500213700229?httpAccept=text/plain
Journal of Thoracic Oncology10.1097/jto.0b013e318174e981200836S143-S145First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in EGFR Mutation; Positive Non-small Cell Lung Cancer PatientsLecia V. Sequisthttp://api.elsevier.com/content/article/PII:S155608641533121X?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S155608641533121X?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)92212-81994115-6430-431Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852http://api.elsevier.com/content/article/PII:0169500294922128?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:0169500294922128?httpAccept=text/plain